Palingenesis Manufacturing Inc. signs worldwide agreement with FranTech to market their Palingenesis proprietary waste processing systems for the treatment of MSW, industrial and commercial waste including hospital waste licensing in 220 countries.
Palingenesis Manufacturing Inc. signed a non-exclusive agreement with FranTech International Licensing, Inc. (FranTech), of Ventura, California, which grants FranTech the right to market Palingenesis’s patented waste treatment and processing systems licensing through FranTech's network of agents in 220 countries to governments, institutions and MSW Enterprises around the world.
The company explained that the Palingenesis is uniquely suited to meet the waste management needs of most if not all countries. Palingenesis, a manufacture of proprietary equipment and sole owner of the Palingenesis Patented Treatment and Process that treats MSW and almost all other types of industrial and commercial waste will be marketed to governments and municipalities throughout the Frantech network of 220 countries with over 600 representatives. Palingenesis waste treatment, processing and conversion systems will also be targeted by Frantech to the private sector though joint venture partnerships or out right sales for the highly profitable business of treating and processing Hazardous and toxic waste which is generated in the millions of metric tones each year.
Ted J. Staley, Chairman of Palingenesis Manufacturing Inc. and its subsidiary company, Pathogenesis Inc. said, "We chose FranTech not only because of their tremendous geographic reach and proven track record in establishing master distributorship agreements but their commitment to the environment. With more than 35 years of experience, FranTech knows international trade policy, law, marketing, investment banking, and technology research. Their broad expertise, coupled with access to key governmental and financial institutions and decision makers, provides services uniquely valuable to Palingenesis."
The company explained that FranTech's mission is to foster the development of the global economy by providing a global perspective to developers, marketers, manufacturers and innovators on newly emerging and preemptive technologies. They offer world-class solutions for the licensing and transfer of USA and global innovations to emerging economies.
Philip Nadeau, CEO of Global FranTech Group, said, "We see a tremendous market worldwide for their revolutionary Waste treatment and processing systems that not only treat and process the waste but convert it in to usable concrete replacement products such as building blocks, roof tiles, sewage pipe, curb siding, paving slabs, and much, much more and we already have interest from several countries. We plan on developing brand name recognition and positioning of Palingenesis with many governmental agencies and private sectors throughout the world where we already have relationships in place. Phillip Nadeau went on to say, "what could be more important today then protecting and saving our environment for ourselves and for generation to come and at the same time the Palingenesis system operates at a profit, a win, win for everyone.".
About Palingenesis Manufacturing Inc/ Pathogenesis Inc.
Palingenesis Manufacturing Inc. (palingenesismfg.com) is a company dedicated to the design, manufacture and operation of proprietary equipment intended for the treatment and processing of Municipal Solid Waste and most types of the Industrial, Commercial, Hazardous and Toxic Waste including Hospital, Solid, Liquid and Sludge Wastes that are generated in today’s market.
Palingenesis began developing its process technology over seven (7) years ago and after thousands of trials and hundreds of laboratory tests on a wide range of diverse waste streams, carried out using the Palingenesis proprietary chemical mixtures/formulas and additives the company can state with authority that its process and machinery have no peers, either in the ability to treat the various waste streams or operate at positive cash flow.
Palingenesis has fully proven tested and verified formulas that effectively treat the majority of different types of hazardous and toxic and non hazardous and non toxic waste materials and convert them into useable by-products that are not only safe for the environment but also economically viable. Palingenesis has spent in excess of PHP200 Million in developing the equipment and technology that can produce environmentally sound and cost effective results which today’s global market demands.
The Palingenesis Process went though over 10 months of rigorous testing and evaluation by Industrial Technology Development Institute, the Environmental Division of the Department of Science and Technology of the Philippine Government. The ITDI concluded that the Palingenesis Process lives up to its claims of being able to successfully treat MSW and most types of industrial and commercial hazardous and toxic waste.
“The percentage of retained heavy metal concentration levels demonstrates that the application of the Palingenesis Process resulted in high efficiency in excess of 99.9%”.
The Palingenesis Process meets and exceeds all U.S. EPA, TCLP and SPLP standards as well as all US, European and Asian air emissions and noise regulations.
We, at Palingenesis, know that the world is now demanding a proven environmentally safe and commercially viable method for the treatment of MSW and hazardous and toxic waste which runs into billions of tonnes generated annually throughout our ever shrinking world. Palingenesis stands at the forefront of being not only a manufacture of proprietary waste treatment and processing equipment, but also a technology provider for ongoing development of environmentally friendly treatments for all types of waste. Palingenesis currently has 7 Patents pending for machine design and waste processing applications.
The problems facing Municipalities and the commercial generators of waste world wide are escalating and Palingenesis offers a sound, commercially viable and environmentally safe solution.
Palingenesis owns and operates though its subsidiary company, Gennix/Pathogenesis Inc. a 36,500 metric tonne per year hazardous and toxic waste treatment and processing centre in Metro Manila, Philippines and has sold plants to the city of Vladivostok Russia and Bahrain. Sales are in the final funding stage in India, Nigeria and China.
At Palingenesis, we have assembled a professional team “TEAM PALINGENESIS” of upper and mid level management that will ensure our place in the market. Mr. Ted J. Staley has the position of Chairman and Mr Brian Ellidge is the Managing Director and with a team of 14 qualified engineers and over 80 wielders, machine operators’ technicians etc. both in the Philippines and abroad. Palingenesis is a company that meets both the environmental and the financial requirements of municipalities and waste generators worldwide.
Team Palingenesis is committed to living up to the meaning of its company’s name, Palingenesis: “Rebirth from the ashes, Regeneration”.
About FranTech International Licensing, Inc.
FranTech consists of core partners surrounded by interlocking networks of consultants and affiliates in key trading countries and disciplines. They have over thirty-five years of experience with their proven partners. In addition, FranTech has proven track records in assembling, negotiating and consummating trade, licensing, technological and financial agreements; they pool strengths drawn from experience in international trade policy, law, marketing, investment banking and technology research.